Maryam Fouladi

Nationwide Children's Hospital — United States

Medicine · Health Sciences

75h-index23.1kcitations473works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(305), Neuroblastoma Research and Treatments(134), Chromatin Remodeling and Cancer(48), Brain Metastases and Treatment(35), Radiomics and Machine Learning in Medical Imaging(30)

Publications466 total

Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children’s Oncology Group
Neuro-Oncology·2025
Outcomes following radiotherapy for atypical teratoid/rhabdoid tumor in combination with surgery and intensive chemotherapy: A report from Children’s Oncology Group study ACNS0333
Neuro-Oncology Pediatrics·2025Open Access
Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy
Neuro-Oncology Advances·2025Open Access
TIP-30. Molecularly-guided phase 2 umbrella trial for children and young adults with newly-diagnosed high-grade glioma (HGG) including diffuse intrinsic pontine glioma (DIPG): CONNECT TarGeT (Targeted pediatric HGG therapy) trial in progress
Neuro-Oncology·2025Open Access
IMMU-79. An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13
Neuro-Oncology·2025Open Access
IMGP-04. Targetable somatostatin receptor expression assessed by DOTATATE PET imaging in children and young adults with recurrent/progressive high-risk central nervous system (CNS) tumors: Initial screening results from the CONNECT2007 Lutathera Phase I/II trial
Neuro-Oncology·2025Open Access
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival
Neuro-Oncology·2025Open Access
IDH mutant high-grade gliomas
Frontiers in Molecular Neuroscience·2025· 1 citedOpen Access
MRD4U: A path to development for personalized liquid biopsy for children with central nervous system tumors
BMC Cancer·2025· 1 citedOpen Access
Childhood cancer data initiative: expanded access to tumor molecular profiling for children, adolescents, and young adults
JNCI Journal of the National Cancer Institute·2025· 4 citedOpen Access
CCDI-COG molecular characterization initiative: The expanding data on childhood cancer.
Journal of Clinical Oncology·2025
Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group
Neuro-Oncology·2025· 9 citedOpen Access
Efficacy of DNA Methyltransferase Inhibitor Immune Priming Therapy in Combination with PD-1 Inhibitors to Treat High-Risk Pediatric Brain Tumors
2025Open Access
A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4
Neuro-Oncology·2025· 8 cited
Pediatric Brain Tumors
Elsevier eBooks·2025
Intratumoral/Peritumoral Herpes Simplex Virus-1 Mutant HSV1716 in Pediatric Patients with Refractory or Recurrent High-Grade Gliomas: A Report of the Pediatric Brain Tumor Consortium
Onco·2024· 2 citedOpen Access
Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors
JAMA Oncology·2024· 12 cited
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study
Neuro-Oncology·2024· 7 citedOpen Access
PATH-13. MOLECULAR AND BIOLOGY CORRELATIVE RESULTS FROM THE PHASE 1B TRIAL OF UNESBULIN (PTC596) WITH RADIOTHERAPY IN CHILDREN NEWLY-DIAGNOSED WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG): A REPORT FROM THE COLLABORATIVE NETWORK FOR NEURO-ONCOLOGY CLINICAL TRIALS (CONNECT)
Neuro-Oncology·2024Open Access
CTIM-06. OUTCOME OF PATIENTS WITH RECURRENT MEDULLOBLASTOMA AND EPENDYMOMA TREATED WITH PEMBROLIZUMAB, AN IMMUNE CHECKPOINT INHIBITOR: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045)
Neuro-Oncology·2024· 1 citedOpen Access
page 1 of 24Next →

Frequent Co-authors

Amar Gajjar(21), Roger J. Packer(18), Ian F. Pollack(14), David Jones(13), Cynthia Hawkins(13), Larry E. Kun(12), Nada Jabado(11), Stefan M. Pfister(11), Thomas E. Merchant(11), Stewart Goldman(10), Marc Remke(9), Éric Bouffet(9), Clinton F. Stewart(9), Richard J. Gilbertson(9), Jason Fangusaro(9), Michael D. Taylor(8), James M. Boyett(8), Sridharan Gururangan(8), Marcel Kool(7), Rachid Drissi(7)